Navigation Links
Novel Photoconductive Life Science Research Innovation Enables Rapid, Reproducible, and Non-Invasive Cellular Excitation
Date:9/19/2008

e fashion. Neurosilicon is comprised of a multidisciplinary team of neuroscientists and engineers. Together this team has spent three years developing, testing, and optimizing their novel photoconductive stimulation technology, significantly advancing the boundaries of life science research.

For more information on the Photoconductive Stimulation Device (PSD), or to order, please visit http://www.neurosilicon.com.


'/>"/>
SOURCE Neurosilicon
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
2. Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)
3. Novel Compound Shows Promise for Treatment of Alcoholism
4. Major State Grant Accelerates Research and Development of Novel Cancer Therapy
5. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
6. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
7. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
8. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
9. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
10. Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
11. Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) ... Amended Plan of Reorganization and related amended Disclosure Statement with ... ,, A hearing to consider the adequacy of ... with the hearing on the confirmation of the Plan scheduled ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Shared Imaging, LLC, an independent provider of CT, ... hospitals and healthcare providers, is excited to announce ... Ambulatory Health Care, a nationally-recognized, prestigious gold seal ... care. Shared Imaging accreditation is system-wide for its ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2New research program BioInterfaces launched 8742 1New research program BioInterfaces launched 8742 2Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 1Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 3
... CAMBRIDGE, Mass., and BERLIN, Sept. 26 ,Genzyme Corporation ... AG, Germany,today announced that the first patient has ... 3 trials examining the safety and efficacy of ... The CARE-MS I trial (Comparison of Alemtuzumab and ...
... 26 Innocoll, Inc., a privately-held,specialty pharmaceutical company, ... clinical development programs and specialty,pharmaceutical operations: - ... in 2007., - GENTAMICIN ... multi-centered clinical trials for the ...
Other Medicine Technology:Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 2Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 3Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 4Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 5Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 6Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 2Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 3Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 4Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 5Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 6
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Blood clotting, ... excessive bleeding when a blood vessel is injured. ... vessels without an obvious injury or do not ... Research presented today at the 51st Annual Meeting ... the practice of using the anticoagulants aspirin and ...
(Date:12/6/2009)... & Fox, LLP says dangerous substances such as asbestos have been ... ... New York, NY (PRWEB) December 6, 2009 -- As parents shop ... to reports of recalls due to lead paint or asbestos contamination, ... children visit hospital emergency rooms each year due to toy-related injuries,” ...
(Date:12/5/2009)... TOWN, South Africa, December 5 The first ... of Cape Town opened its doors,today (5 December ... by,Western Cape Premier Helen Zille, 2010 FIFA World ... South African Football Association,President Kirsten Nematandani and Executive ...
(Date:12/5/2009)... with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) ... birthday without ever tying the knot, since research has shown ... And, um, isn,t there something wrong with those who go ... study looking at psychological measures shows that never-married people aged ...
(Date:12/5/2009)... the most unusual places, and to do everything from growing mushrooms, making ... ... -- Who would have thought that your wine, water and vegetables would ... announced a new line of turbines, for industry end users, not wind ...
Breaking Medicine News(10 mins):Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
... University of Maryland at Baltimore has been chosen by The ... T. Freeman Award. This honor, given annually, is a lectureship ... the field of aging - both in research and practice ... section. , The award presentation will take place at GSA,s ...
... In Israel stamp on it? American donors to the Israel ... chance it could. , In September 2007, the ICRF gave ... Shiloh from the Department of Human Molecular Genetics and Biochemistry, ... more to eight other researchers at the university in a ...
... better prepare us for diseases in our future. This, in ... a professor emeritus of biology at the University of California, ... Our World (American Society for Microbiology Press, 2007), which ... diseases that greatly influenced society, politics and culture. ...
... PHYSICIAN COMPENSATION AND PRODUCTIVITY SURVEY ... by Sullivan, Cotter and Associates, Inc., CHICAGO, ... published its 2007 Physician Compensation and Productivity Survey,Report, ... The survey,report outlines: base salary, total cash compensation ...
... in partnership with Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) ... influenza to help protect ... conducted be at Town Center at Aurora during ... this special time of year, - ...
... Report and Media Briefing Explore,Impact of Hormonal Transitions ... Women are more,susceptible to mood disorders and ... perimenopause, according to a new report,by the Society ... released at a media briefing held at the ...
Other Medicine News:Health News:American donors put faith (and dollars) in TAU cancer research 2Health News:American donors put faith (and dollars) in TAU cancer research 3Health News:New book by UCR biologist discusses 12 diseases that impacted humanity 2Health News:Compensation Decreases Indicated for Physicians 2Health News:Compensation Decreases Indicated for Physicians 3Health News:Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers 2Health News:Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers 3Health News:Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers 4Health News:Hormonal Changes and Depression: What is the Connection? 2Health News:Hormonal Changes and Depression: What is the Connection? 3Health News:Hormonal Changes and Depression: What is the Connection? 4
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
Seamlessly integrates with the i2000SR to form a state-of-the-art immunochemistry platform, the ci8200. Flexibility to prioritize STAT, automated rerun/dilution, and reflex testing over routines to e...
... and controls interchangeable with other Roche/Hitachi ... training costs. Consistent patient results throughout ... handling. 70 positions for routine, STAT ... volumes. Intermix sample types. Intermix 5 ...
Modular Pre-Analytics is an integral component of the new modular systems platform which combines pre-analytics, clinical chemistry and immunochemistry....
Medicine Products: